LATEST
Intelligent Protection Management agreed to acquire AdTech ITnewJanel agreed to acquire EnCor BiotechnologyNightfood Holdings acquired Jun Long Machine IndustrialClimb Global Solutions acquired NeoVADValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range Intermediate
Open App
Agreement signedPublished 13 Jan 2022

Salarius Pharmaceuticals, Inc. /
DeuteRx, LLC

Salarius Pharmaceuticals Agrees to Purchase DeuteRx Assets

Terms
Not stated
Stage
Agreement signed
Source · 13 Jan 2022
See the source
01 / BuyerSalarius Pharmaceuticals, Inc.
02 / TargetDeuteRx, LLC
01

What happened

Salarius Pharmaceuticals, Inc. agreed to purchase certain assets from DeuteRx, LLC, including assets related to the development product DRX-164.

The purchase price includes $1,500,000 U.S. Dollars and one million shares of Salarius Pharmaceuticals, Inc. common stock.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Salarius Pharmaceuticals Agrees to Purchase DeuteRx Assets

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.